Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo - Wikidata - wikimedia - TriplyDB

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

http://www.wikidata.org/entity/Q24648007

about

Metabolomics of human brain aging and age-related neurodegenerative diseases 18F-florbetaben Aβ imaging in mild cognitive impairment Contributions of academic laboratories to the discovery and development of chemical biology tools A Network Diffusion Model of Disease Progression in Dementia PET amyloid-beta imaging in preclinical Alzheimer's disease Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.The link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.A review of β-amyloid neuroimaging in Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.In vivo human amyloid imaging.Clinicopathologic characteristics, prevalence, and risk factors of spontaneous diabetes in sooty mangabeys (Cercocebus atys).An expanded role for neuroimaging in the evaluation of memory impairment.Insulin blocks glutamate-induced neurotoxicity in differentiated SH-SY5Y neuronal cells New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Neuroimaging in Alzheimer's disease: current role in clinical practice and potential future applications.White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?Association between neuropathology and brain volume in the Framingham Heart Study.Imaging approaches for dementia.Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults.Bapineuzumab Insulin resistance predicts brain amyloid deposition in late middle-aged adults.Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease Modifications of hippocampal circuits and early disruption of adult neurogenesis in the tg2576 mouse model of Alzheimer's disease.Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging Predicting MCI outcome with clinically available MRI and CSF biomarkers.Not quite PIB-positive, not quite PIB-negative: slight PIB elevations in elderly normal control subjects are biologically relevant Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.APOE modifies the association between Aβ load and cognition in cognitively normal older adults.Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues.Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications.Evidence for ordering of Alzheimer disease biomarkers Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease Neuroimaging predictors of brain amyloidosis in mild cognitive impairment.

P2860

Q26992344-09942B30-04CC-4A72-8B2B-6403F4CA5795 Q27499311-7E0C9E0C-042F-405B-BADE-1AA5E6845478 Q28389188-2F1704EF-64D0-4E18-9434-6DB4F46CDD96 Q29543923-DA1B0C0A-FABA-4E8A-AABF-6AA0002C3054 Q30040695-AA6B50E0-601D-4472-A8C7-214B751DB736 Q30499456-A8E63DD4-EBC8-4BEF-82FA-BEF7981365B5 Q30580439-887F3152-F2AF-4F73-9E47-68D16C9658CA Q30667035-8C8865D6-E6E3-434F-A593-27278AC8904B Q30830414-D197D796-96E9-4F8A-937E-4723AFD215D5 Q30870063-B0546E84-B833-4F0C-AC5C-D208AECBB17E Q33729033-D689BFCB-3D6B-49A8-8184-5734ED2C0BA0 Q33759008-21801078-8090-4BD4-9B2C-D137A78C3BA4 Q33790277-7597C0BD-C64B-48A4-880B-D5FDD69933BA Q33794617-51639D83-9034-4BAF-BDDB-35ACAD04E763 Q33830698-F724B5A1-9B56-4005-8FC1-669DD84DDF32 Q33849819-7B22BE4C-7809-4363-8819-B751E3C3EA30 Q33881726-67AFC736-0798-46E7-B18D-3A736DC7A3AA Q33968419-D55BC4A3-E4DD-47AC-B289-E95AE8B49235 Q34013887-2892375C-9D7F-4619-BB37-5893F768B058 Q34071079-875068E0-2628-4BEC-8D18-BCF40FF6DF00 Q34089121-75A1E7C2-0C98-4FA9-9EE5-FFA96251B8D1 Q34110934-41C424E5-7ADF-4E41-A0AE-56DD4CDBD268 Q34176310-537275FD-3027-47DA-88EE-7CEE2D166EFB Q34311853-1F38112A-2E33-4F3D-9174-7F851E2BE9C5 Q34398107-A9E09761-7640-4C87-A545-98A21E11FA7D Q34429975-2ADFA04E-08AB-46C2-87DC-76A4CA121E12 Q34460952-DA97213C-D472-42D6-A626-0B763973A44A Q34620948-C2963FCA-148A-488B-8A37-7E3B05A5F24E Q35006372-F6F0D5E3-10D6-4E70-AADE-68ACD8FD4BD7 Q35204334-D9000A0C-6845-4E45-A268-4FAB42E6736D Q35416716-20247D37-11CA-4FFD-9D28-906194A5740B Q35592672-D6B90453-1CBD-468A-9415-60535B55A72B Q35667139-5DF39531-3F0D-4E77-9F47-CCCF5441BBB9 Q35687048-03E7E8A0-C557-4F68-B51D-5E0F5F7F3869 Q35758673-45DC0A8D-1772-4536-BFB3-5DF73467E6B9 Q35838385-A7A45AD1-D418-4E22-8322-32588BA32490 Q35840614-8CB1A99B-67DF-4FD9-9692-B368D89B0C4C Q36071403-C39A1E9C-D26D-4977-B8AF-18275C85DA6C Q36081889-31418C42-ABFE-4B87-9D3A-B0CFD35835F2 Q36155517-FF1B8449-B2FE-496C-9BF3-99BADFB54587

P2860

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

http://www.wikidata.org/entity/Q24648007

description

2009 nî lūn-bûn

@nan

2009 թուականին հրատարակուած գիտական յօդուած

@hyw

2009 թվականին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@ast

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@en

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@nl

type

label

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@ast

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@en

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@nl

prefLabel

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@ast

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@en

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@nl

P1433

Q24648007-26ACB858-5534-44E8-BF64-7EB98426D671

P1476

Q24648007-FEA86EDB-C41C-4A6F-8A91-966E4E8E6C04

P2093

Q24648007-421FA3CB-11FD-420F-8519-DF28C2BAF03F

Q24648007-690CF3A0-4145-4334-B1A8-C23174CA8AC9

P275

Q24648007-62917785-DBD1-4FBA-ADF6-924D68A76050

P2860

Q24648007-0AD539DE-83EA-42F1-9A45-FF8453BBB229

Q24648007-0CB20706-3D93-4111-B8F3-5F9245C22B3A

Q24648007-21DFBEF5-EA3B-416A-93DC-EAD53D839F42

Q24648007-2C3E0B6A-D8DD-4FA3-9D57-CEF2050B86FC

Q24648007-3C7A3C75-48CC-4FCC-A618-F9DAB35B2E6B

Q24648007-4C327DC2-4BC8-4C7D-9E4C-273EB8A0C118

Q24648007-56365D0E-4001-4088-A016-79BADA26D87F

Q24648007-5BE75672-152D-4149-B271-73C17B1F96B4

Q24648007-B5CDD369-23A5-4DBB-A5B7-15866016ABE3

Q24648007-DC5B47B5-A28E-44D0-A165-CDC8F5BE9D14

P304

Q24648007-165926ED-C0D6-4376-8EFE-06CA3E8021CA

P31

Q24648007-3FF4270D-9A48-45B9-B357-A038B53F866B

Q24648007-7AEEEB82-5C1A-4EB3-98C5-50A1CADEDED9

P3181

Q24648007-139E73F7-66AD-42A3-B86B-BE5C174CC087

P356

Q24648007-A895CE92-FA09-4504-919B-C70804B051AA

Q24648007-FEF6F312-1D5D-46F3-BAB3-0963B7EB7F98

P407

Q24648007-C16D5423-83E5-4E4B-A599-C803E5BC6917

P433

Q24648007-50DA71B0-369C-4770-B0F8-1B77E50E640E

P478

Q24648007-92B2A2A1-B72A-40FD-A9BB-93DF004B54F8

P5008

Q24648007-767F3503-993E-4B8A-923B-1F6EACFD883A

P577

Q24648007-3FEA48E5-B344-49A7-9867-D5B1BB58D5FD

P698

Q24648007-E8EF90C3-A612-4076-823C-D7A108E48E7A

P921

Q24648007-0D0F908F-9502-490C-B19B-CC43965401EA

Q24648007-4A75EB30-3D1E-4B56-92A8-EC5B5E54F4DF

Q24648007-5285AC58-E714-4295-A179-502F10C21439

Q24648007-63A9FECC-5D0B-41B2-B00B-8BDC2A6B47B8

Q24648007-68799DDA-4516-4C18-A802-5D5038CB159F

Q24648007-760C8C5E-C227-4F3F-9BAA-ABB3927D12BA

Q24648007-8796EA25-94AF-47F5-A68E-64941CB8E93A

Q24648007-8D2E9977-DF81-45AD-8B72-14D64C193A40

P932

Q24648007-0814BE92-D672-4D87-8F90-E72BFC81AFCE

P3181

P356

P1433

Behavioural Neurology

P1476

Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo

@en

P2093

G D Rabinovici

http://www.w3.org/2001/XMLSchema#string

W J Jagust

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

“Mini-mental state”

Neuropathological stageing of Alzheimer-related changes

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

A beta oligomers - a decade of discovery

The Clinical Dementia Rating (CDR): current version and scoring rules

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease

P304

117-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4423604

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2009/609839

http://www.w3.org/2001/XMLSchema#string

10.3233/BEN-2009-0232

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19847050

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cognitive disorder

amyloid imaging

membrane proteins

physiological phenomena

P932

2804478

http://www.w3.org/2001/XMLSchema#string